The professor of neurology at the University of Cincinnati discussed why disparities persist in secondary stroke prevention and how growing awareness of social determinants of health is helping to close the gap for underserved patients.
|Slideshows|March 28, 2017
Neuro News Roundup: Stroke Outcomes
Author(s)Mark L. Fuerst
Studies include stroke risk with epilepsy, genetic predisposition for ischemic stroke, and dysphagia screening in stroke patients.
Advertisement
New studies on stroke include the following highlights: epilepsy may be an indication of hidden cerebrovascular disease in elderly patients; a model to predict genetic predispositions may provide valuable information about an individual’s risk of ischemic stroke; and about one in 5 patients with acute ischemic stroke are not screened for documented dysphagia, putting them at risk for poorer outcomes.
Advertisement
Related to this article
The FDA lifted a clinical hold on simufilam, clearing Filana Therapeutics, formerly Cassava Sciences, to begin a phase 2a study in TSC-related epilepsy.
Xenon Pharmaceuticals submitted an FDA new drug application for azetukalner, a KV7 potassium channel opener, as adjunctive therapy for focal seizures in epilepsy.
Here's some of what is coming soon to NeurologyLive® this week.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 18, 2026.
A published protocol outlines the randomized, open-label EPOCH trial testing whether cilostazol accelerates hematoma resorption and improves recovery after intracerebral hemorrhage.
Marketed as Fayuvi, the 1-time AAV9 gene therapy showed sustained cerebrospinal fluid heparan sulfate drops and developmental gains among pediatric patients with mucopolysaccharidosis type IIIA in prior studies.
Amy Waldman, MD, Medical Director of the Leukodystrophy Center at Children's Hospital of Philadelphia, discusses zilganersen's mechanism, safety profile, clinical considerations, and what the first-ever approval for Alexander disease means for the broader leukodystrophy field.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Grants Fast Track Designation to Apitegromab for Facioscapulohumeral Muscular Dystrophy
2
Closing the Gaps in Cluster Headache Care: Jennifer Fokas, MD; Minali Nigam, MD
3
Xenon Submits New Drug Application for Azetukalner as Treatment for Focal Seizures
4
Ulefnersen Meets Primary End Point in Phase 3 FUSION Trial for FUS-ALS
5